Bedside To Bench: New Pathways For Understanding IBD
Dr. Aida Habtezion and Stanford University make promising advances through technology and collaboration.
Researchers
Below are researchers funded by the Kenneth Rainin Foundation who are working in immunity and inflammation.
Eric Martens, PhD
Professor, University of Michigan, Former Grantee
The Martens lab investigates the symbiotic microorganisms in the human gastrointestinal tract at multiple levels with the goal of using diet and gut microbial interventions to treat chronic conditions such as Inflammatory Bowel Disease.
Markus Neurath, PhD
Doctor, Friedrich-Alexander-Universität Erlangen-Nürnberg, Former Grantee
Dr. Neurath studies the immunologic and molecular mechanisms in the pathogenesis of Inflammatory Bowel Disease and gastrointestinal cancer to create new therapeutic options for patients.
Timothy Nice, PhD
Associate Professor, Oregon Health & Science University, Former Grantee
The Nice lab studies the biology of the intestinal innate immune cells and cytokines—how they promote intestinal health and resistance to infection. They seek to understand how immune pathways function and become dysfunctional in disease states.
Roni Nowarski, PhD
Assistant Professor, Harvard Medical School, Brigham and Women's Hospital, Current Grantee
The Nowarski lab studies what makes or breaks tissue inflammation with a focus on cytokine signaling, immunometabolism and innate immune memory.
Fiona Powrie, PhD
Professor, University of Oxford, Former Grantee
The Powrie lab is focused on understanding the interaction between the intestinal microbiota and the host immune system and how this mutualistic relationship breaks down in Inflammatory Bowel Disease and cancer.
Gwendalyn Randolph, PhD
Professor, Washington University in St. Louis, Former Grantee
The Randolph laboratory seeks to understand how the clearance of cells and molecules from tissues impacts inflammation, disease states and organ physiology.
